ES2052745T3 - Formulaciones farmaceuticas que contienen melfalan o hidrocloruro de melfalan, asi como melfalan e hidrocloruro de melfalan y procedimientos para prepararlas. - Google Patents
Formulaciones farmaceuticas que contienen melfalan o hidrocloruro de melfalan, asi como melfalan e hidrocloruro de melfalan y procedimientos para prepararlas.Info
- Publication number
- ES2052745T3 ES2052745T3 ES88310805T ES88310805T ES2052745T3 ES 2052745 T3 ES2052745 T3 ES 2052745T3 ES 88310805 T ES88310805 T ES 88310805T ES 88310805 T ES88310805 T ES 88310805T ES 2052745 T3 ES2052745 T3 ES 2052745T3
- Authority
- ES
- Spain
- Prior art keywords
- melfalan
- hydrochloride
- well
- pharmaceutical formulations
- formulations containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- OUUYBRCCFUEMLH-YDALLXLXSA-N [(1s)-2-[4-[bis(2-chloroethyl)amino]phenyl]-1-carboxyethyl]azanium;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 OUUYBRCCFUEMLH-YDALLXLXSA-N 0.000 title abstract 3
- SGDBTWWWUNNDEQ-LBPRGKRZSA-N melphalan Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N(CCCl)CCCl)C=C1 SGDBTWWWUNNDEQ-LBPRGKRZSA-N 0.000 title abstract 3
- 229960001924 melphalan Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical class [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878727157A GB8727157D0 (en) | 1987-11-19 | 1987-11-19 | Pharmaceutical formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2052745T3 true ES2052745T3 (es) | 1994-07-16 |
Family
ID=10627252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES88310805T Expired - Lifetime ES2052745T3 (es) | 1987-11-19 | 1988-11-16 | Formulaciones farmaceuticas que contienen melfalan o hidrocloruro de melfalan, asi como melfalan e hidrocloruro de melfalan y procedimientos para prepararlas. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4997651A (fr) |
| EP (1) | EP0317281B1 (fr) |
| JP (1) | JP2693191B2 (fr) |
| KR (1) | KR970002607B1 (fr) |
| AT (1) | ATE83922T1 (fr) |
| AU (1) | AU619781B2 (fr) |
| CA (1) | CA1341114C (fr) |
| DE (1) | DE3877151T2 (fr) |
| DK (1) | DK172794B1 (fr) |
| ES (1) | ES2052745T3 (fr) |
| FI (2) | FI90204C (fr) |
| GB (1) | GB8727157D0 (fr) |
| GR (1) | GR3007287T3 (fr) |
| HK (1) | HK108994A (fr) |
| HU (3) | HU203197B (fr) |
| IE (1) | IE63996B1 (fr) |
| IL (1) | IL88419A (fr) |
| LV (1) | LV10179B (fr) |
| NZ (2) | NZ239867A (fr) |
| PT (1) | PT89028B (fr) |
| SG (1) | SG73894G (fr) |
| ZA (1) | ZA888674B (fr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5407672A (en) * | 1993-04-08 | 1995-04-18 | Cornell Research Foundation, Inc. | Enhancing the anti-tumor effect of melphalan with L-amino acid oxidase |
| US5695751A (en) * | 1993-04-08 | 1997-12-09 | Cornell Research Foundation, Inc. | Enhancing delivery of large neutral amino acid drugs |
| US6020004A (en) * | 1997-04-17 | 2000-02-01 | Amgen Inc. | Biodegradable microparticles for the sustained delivery of therapeutic drugs |
| US5980904A (en) * | 1998-11-18 | 1999-11-09 | Amway Corporation | Skin whitening composition containing bearberry extract and a reducing agent |
| GB2386066A (en) * | 2002-02-28 | 2003-09-10 | Norbrook Lab Ltd | Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species |
| AU2003253681B2 (en) * | 2002-06-24 | 2008-05-01 | Research Development Foundation | Treatment of human multiple myeloma by Curcumin |
| EP1694335A4 (fr) | 2003-08-26 | 2008-12-31 | Res Dev Foundation | Inhibiteurs d'osteoclastogenese et leurs utilisations |
| US8501818B2 (en) | 2005-03-14 | 2013-08-06 | Ceptaris Therapeutics, Inc. | Stabilized compositions of alkylating agents and methods of using same |
| US8501817B2 (en) | 2005-03-14 | 2013-08-06 | Ceptaris Therapeutics, Inc. | Stabilized compositions of alkylating agents and methods of using same |
| US7872050B2 (en) | 2005-03-14 | 2011-01-18 | Yaupon Therapeutics Inc. | Stabilized compositions of volatile alkylating agents and methods of using thereof |
| AR066943A1 (es) * | 2008-06-10 | 2009-09-23 | Eriochem Sa | Una composicion farmaceutica de melfalano |
| US11020363B2 (en) | 2009-05-29 | 2021-06-01 | Cydex Pharmaceuticals, Inc. | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same |
| KR101522918B1 (ko) * | 2009-05-29 | 2015-05-27 | 사이덱스 파마슈티칼스, 인크. | 사이클로덱스트린 유도체를 포함하는 주사용 멜팔란 조성물 및 이의 제조 및 사용 방법 |
| AR077384A1 (es) | 2010-07-05 | 2011-08-24 | Eriochem Sa | Una formulacion farmaceutica inyectable de melfalano. |
| US8921596B2 (en) * | 2010-11-04 | 2014-12-30 | Emcure Pharmaceuticals, Ltd. | Process for the preparation of melphalan hydrochloride |
| SI3228319T1 (sl) | 2011-04-28 | 2020-10-30 | Oncopeptides Ab | Liofiliziran pripravek citotoksičnih dipeptidov |
| JP6284945B2 (ja) * | 2012-10-26 | 2018-02-28 | オンコペプティデス エービーＯｎｃｏｐｅｐｔｉｄｅｓ ＡＢ | メルファランフルフェナミドの凍結乾燥製剤 |
| EP2970102B1 (fr) | 2013-03-11 | 2019-05-08 | Biophore India Pharmaceuticals Pvt. Ltd. | Procédé perfectionné pour la synthèse de melphalan et de son sel chlorhydrate |
| ITMI20130896A1 (it) | 2013-05-31 | 2014-12-01 | Farmabios Spa | Processo di purificazione di melphalan |
| US10576101B2 (en) | 2015-03-06 | 2020-03-03 | Leadiant Biosciences Sa | Roneparstat combined therapy of multiple myeloma |
| WO2017002030A1 (fr) * | 2015-06-30 | 2017-01-05 | Leiutis Pharmaceuticals Pvt Ltd | Formulations liquides stables de melphalan |
| JP7464995B2 (ja) * | 2018-03-29 | 2024-04-10 | プロジェクト ファーマシューティクス ゲーエムベーハー | 液体薬学的製剤 |
| US10682326B1 (en) | 2019-06-03 | 2020-06-16 | Shilpa Medicare Limited | Stable melphalan liquid injectable formulations |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB750155A (en) * | 1953-03-17 | 1956-06-13 | Nat Res Dev | Substituted alanines |
| US3032585A (en) * | 1954-12-03 | 1962-05-01 | Nat Res Dev | Process for the production of p-bis-(2-chloroethyl)-aminophenylalanine |
| DE1292660B (de) * | 1963-04-24 | 1969-04-17 | Ural Polytechnitscheskij I Im | Verfahren zur Herstellung von p-(Bis-ª‰-chloraethyl-amino)-phenylalanin-hydrochlorid |
| US4029778A (en) * | 1969-01-23 | 1977-06-14 | Aktiebolaget Leo | Cortical steroid nitrogen mustard compositions and treatment therewith |
| RO57195A2 (fr) * | 1970-11-30 | 1974-09-01 | ||
| FR2285855A1 (fr) * | 1974-09-25 | 1976-04-23 | Kohjin Co | Composition therapeutique lyophilisee a base de sel de cyclocytidine et son procede de preparation |
| JPS59186924A (ja) * | 1983-04-08 | 1984-10-23 | Kureha Chem Ind Co Ltd | ヒト免疫グロブリン結合抗腫瘍剤 |
| US4696814A (en) * | 1985-08-21 | 1987-09-29 | Warner-Lambert Company | Parenteral phenytoin compositions |
| JPS62192357A (ja) * | 1986-02-19 | 1987-08-22 | Kureha Chem Ind Co Ltd | Ｎ−フタロイル−ｐ−ニトロ−Ｌ−フエニルアラニンの製造方法 |
-
1987
- 1987-11-19 GB GB878727157A patent/GB8727157D0/en active Pending
-
1988
- 1988-11-16 EP EP88310805A patent/EP0317281B1/fr not_active Expired - Lifetime
- 1988-11-16 AT AT88310805T patent/ATE83922T1/de not_active IP Right Cessation
- 1988-11-16 ES ES88310805T patent/ES2052745T3/es not_active Expired - Lifetime
- 1988-11-16 DE DE8888310805T patent/DE3877151T2/de not_active Expired - Lifetime
- 1988-11-18 IE IE344788A patent/IE63996B1/en not_active IP Right Cessation
- 1988-11-18 US US07/273,227 patent/US4997651A/en not_active Expired - Lifetime
- 1988-11-18 DK DK198806466A patent/DK172794B1/da not_active IP Right Cessation
- 1988-11-18 AU AU25748/88A patent/AU619781B2/en not_active Expired
- 1988-11-18 PT PT89028A patent/PT89028B/pt not_active IP Right Cessation
- 1988-11-18 KR KR1019880015196A patent/KR970002607B1/ko not_active Expired - Lifetime
- 1988-11-18 CA CA000583540A patent/CA1341114C/fr not_active Expired - Fee Related
- 1988-11-18 NZ NZ239867A patent/NZ239867A/en unknown
- 1988-11-18 HU HU885953A patent/HU203197B/hu unknown
- 1988-11-18 HU HU91335A patent/HU207286B/hu unknown
- 1988-11-18 HU HU91336A patent/HU206671B/hu unknown
- 1988-11-18 IL IL88419A patent/IL88419A/xx not_active IP Right Cessation
- 1988-11-18 FI FI885358A patent/FI90204C/fi not_active IP Right Cessation
- 1988-11-18 NZ NZ227004A patent/NZ227004A/xx unknown
- 1988-11-18 ZA ZA888674A patent/ZA888674B/xx unknown
- 1988-11-18 JP JP63292228A patent/JP2693191B2/ja not_active Expired - Lifetime
-
1992
- 1992-10-15 FI FI924668A patent/FI102275B/fi not_active IP Right Cessation
-
1993
- 1993-03-09 GR GR930400510T patent/GR3007287T3/el unknown
- 1993-12-28 LV LVP-93-1379A patent/LV10179B/en unknown
-
1994
- 1994-06-03 SG SG73894A patent/SG73894G/en unknown
- 1994-10-06 HK HK108994A patent/HK108994A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2161085T3 (es) | Formulaciones que contienen oxaliplatino. | |
| ES2038337T3 (es) | 2,2-difluorociclopropiletano, procedimientos para su preparacion y su utilizacion como agentes plaguicidas. | |
| ES2142798T3 (es) | Derivados de 3-amido pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| SE8602723L (sv) | Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem | |
| ES2018478B3 (es) | Un sistema para preparar una composicion desensibilizante dental. | |
| DK281184A (da) | Galeniske praeparatformer for orale antidiabetica og fremgangsmaade til deres fremstilling | |
| ES2061727T3 (es) | Sustancias fisiologicamente activas, un procedimiento para su preparacion y composiciones farmaceuticas que las contienen. | |
| LV10179A (lv) | Farmaceitiski sastavi kas satur melfalanu vai melfalana hidrohloridu ka ari melfalans un melfalana hidrohlorids un panemieni to iegusanai | |
| DK0482097T3 (da) | Tensidpræparater og fremgangsmåder | |
| PT98371A (pt) | Processo para a preparacao de derivados 6-alcoxi de arabinofuranosil-guanina e de composicoes farmaceuticas que os contem | |
| PT88306A (pt) | Processo para a preparacao de nucleosidos de 2', 3'-dideoxi-3'-fluoro-pirimidina e de composicoes farmaceuticas que os contem | |
| AR006345A1 (es) | Una composicion farmaceutica para administracion oral que comprende un inhibidor de proteasa del vih y un derivado de tocoferol soluble en agua, y un metodo para preparar dicha composicion. | |
| ATE945T1 (de) | Antikoagulierungsmittel, verfahren zu dessen herstellung und es enthaltende pharmazeutische zusammensetzungen. | |
| ES2037682T3 (es) | Procedimiento para la preparacion de composiciones farmaceuticas empleando quitosanos metilados. | |
| DK429480A (da) | Phosphonohydroxyeddikesyre fremgangsmaader til fremstilling deraf samt anvendelse deraf som laegemiddel | |
| ES2052484T1 (es) | N-(5-tioxo-l-prolil)-l-cisteina, sus derivados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| IT7926854A0 (it) | Derivato di creatinolo o-fosfato ad azione terapeutica, procedimento per la sua preparazione e relativ-e composizioni farmaceutiche. | |
| SE8006550L (sv) | Farmakologisk komposition, samt sett for dess framstellning | |
| SE8306225L (sv) | 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma | |
| ES2178760T3 (es) | Uso de 2-mercaptoetanosulfanato de sodio en cirugia. | |
| DK52080A (da) | Dehydropeptider fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler | |
| DK430380A (da) | Fremgangsmaade til fremstilling af piperidinderivater af 4,5-dialkyl-3-hydroxypyrrol-2-carboxylsyreestere | |
| SE8101884L (sv) | Farmaceutiska preparat | |
| ES2120966T3 (es) | 1'-aminoespiro(isoquinolino-4(1h),3'-pirrolidino)-1,2',3,5'(2h)-tetronas y analogos de las mismas utiles como inhibidores de la aldosa reductasa in vivo. | |
| ES2054029T3 (es) | Formulacion de acetato de flecainida con liberacion controlada. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 317281 Country of ref document: ES |